RAC 2.92% $1.94 race oncology ltd

Ann: Zantrene highly effective in Melanoma preclinical study, page-20

  1. 1,287 Posts.
    lightbulb Created with Sketch. 187
    Fantastic news. This will certainly get the big pharmaceutical companies interested
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.